SCHEMBL4546305

SCHEMBL4546305

BC(B)B

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL333801 0.71
SCHEMBL6747842 0.67
SCHEMBL23628375 0.61
SCHEMBL10016147 0.61
SCHEMBL21294948 0.61
SCHEMBL3390842 0.61
SCHEMBL16249962 0.61
SCHEMBL10019298 0.61
SCHEMBL9082104 0.58
SCHEMBL9615417 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239788-A1 SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT TAIHO PHARMACEUTICAL CO., LTD. (JP) 2024-07-18 US disclosed
US-20240216276-A1 PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2024-07-04 US disclosed
US-20240016736-A1 PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2024-01-18 US disclosed
US-11759422-B2 Pegylated liposomes for delivery of immunogen-encoding RNA GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2023-09-19 US disclosed
EP-4226941-A1 PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA GlaxoSmithKline Biologicals S.A. (BE) 2023-08-16 EP disclosed
EP-4226940-A1 PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA GlaxoSmithKline Biologicals S.A. (BE) 2023-08-16 EP disclosed
US-11692061-B2 Fluoro (poly) ether group-containing silane compound DAIKIN INDUSTRIES, LTD. (JP) 2023-07-04 US disclosed
US-20230158151-A1 COMPOUNDS FOR INHIBITING OR DEGRADING TARGET PROTEINS, COMPOSITIONS, COMPRISING THE SAME, METHODS OF THEIR MAKING, AND METHODS OF THEIR USE NURIX THERAPEUTICS, INC. 2023-05-25 US disclosed
US-20230028114-A1 AZOLE-FUSED PYRIDAZIN-3(2H)-ONE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-01-26 US disclosed
EP-4119155-A1 PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA GlaxoSmithKline Biologicals S.A. (BE) 2023-01-18 EP disclosed
US-8147036-B2 Polyfunctional epoxy compound, epoxy resin, cationic photopolymerizable epoxy resin composition, micro structured member, producing method therefor and liquid discharge head CANON KABUSHIKI KAISHA (JP) 2012-04-03 US disclosed
US-8147036-B2 Polyfunctional epoxy compound, epoxy resin, cationic photopolymerizable epoxy resin composition, micro structured member, producing method therefor and liquid discharge head CANON KABUSHIKI KAISHA (JP) 2012-04-03 US disclosed
US-7988953-B2 cosmetic; dendritic polyether; sunscreens DSM IP ASSETS B.V. (NL) 2011-08-02 US disclosed
US-20100305100-A1 METHODS FOR TREATING HEPATITIS C PTC THERAPEUTICS, INC. (US) 2010-12-02 US disclosed
US-20100271428-A1 POLYFUNCTIONAL EPOXY COMPOUND, EPOXY RESIN, CATIONIC PHOTOPOLYMERIZABLE EPOXY RESIN COMPOSITION, MICRO STRUCTURED MEMBER, PRODUCING METHOD THEREFOR AND LIQUID DISCHARGE HEAD CANON KABUSHIKI KAISHA (JP) 2010-10-28 US disclosed
US-20100271428-A1 POLYFUNCTIONAL EPOXY COMPOUND, EPOXY RESIN, CATIONIC PHOTOPOLYMERIZABLE EPOXY RESIN COMPOSITION, MICRO STRUCTURED MEMBER, PRODUCING METHOD THEREFOR AND LIQUID DISCHARGE HEAD CANON KABUSHIKI KAISHA (JP) 2010-10-28 US disclosed
US-7772271-B2 Methods for treating hepatitis C PTC THERAPEUTICS, INC. (US) 2010-08-10 US disclosed
US-20080081025-A1 Uv Absorbing Chromophores Covalently Bonded to Hyperbranched Polymers DSM IP ASSETS B.V. (NL) 2008-04-03 US disclosed
WO-2007148822-A1 POLYFUNCTIONAL EPOXY COMPOUND, EPOXY RESIN, CATIONIC PHOTOPOLYMERIZABLE EPOXY RESIN COMPOSITION, MICRO STRUCTURED MEMBER, PRODUCING METHOD THEREFOR AND LIQUID DISCHARGE HEAD CANON KABUSHIKI KAISHA (JP) 2007-12-27 WO disclosed
US-20070299068-A1 Methods for treating hepatitis C PTC THERAPEUTICS, INC. 2007-12-27 US disclosed